400-968-1881

About TCRCure

TCRCURE

 TCRCure Biopharma Ltd was founded in August 2016 by a team of immunologists and cell engineers from both the USA and China. TCRCure is headquartered in Beijing, China. Over the course of two years, TCRCure has established R&D sites in Los Angeles, California and Research Triangle Park, North Carolina, as well as a translational medicine center in Chongqing, China. In 2017, TCRCure successfully closed Series A funding. This investment was led by multiple professional healthcare venture capital firms, including Share Capital and ETP Biomedical Venture Capital. To date, TCRCure possesses streamlined biotechnology development including vector and cell manufacturing, which enables clinical translation intended for full-fledged immunotherapy services……

TCRCURE

Technology Platform
Clinical Trials

Immune Cell Therapy

T Cell Receptor Sequencing

Technology Platform
Successful Case
Technical Application

Core Techology

TCRCURE

TCRCURE

Data cleaning and pre-analysis

TCR data storage, management and analysis

Sample collection, processing, sequencing, data collection

Application of T Cell Receptor Library Sequencing

TCRCURE

Floor 4, Building 6, 8 shengmingyuan Rd., Lifescience park, Changping

District, Beijing, China

 

No.101 5-10-2 Cuibo Road, Chunhui Street, Dadukou District, Chongqing

© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager

Contact us

400-968-1881